Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Azzarano, L. M."'
Publikováno v:
Xenobiotica. Apr2004, Vol. 34 Issue 4, p353-366. 14p.
Publikováno v:
Xenobiotica; Apr2004, Vol. 34 Issue 4, p367-377, 11p
Autor:
Ward, K. W., Proksch, J. W., Salyers, K. L., Azzarano, L. M., Morgan, J. A., Roethke, T. J., McSurdy-Freed, J. E., Levy, M. A., Smith, B. R.
Publikováno v:
Xenobiotica; Mar2002, Vol. 32 Issue 3, p221-233, 13p
Autor:
Ward, K. W., Proksch, J. W., Azzarano, L. M., Mumaw, J. A., Roethke, T. J., Stelman, G. J., Walsh, M. J., Zeigler, K. S., McSurdy-Freed, J. E., Kehler, J. R, Chokshi, J., Levy, M. A., Smith, B. R.
Publikováno v:
Xenobiotica; Nov2001, Vol. 31 Issue 11, p783-797, 15p
Autor:
Miller, W. H., Alberts, D. P., Bhatnagar, P. K., Bondinell, W. E., Callahan, J. F., Calvo, R. R., Cousins, R. D., Erhard, K. F., Heerding, D. A., Keenan, R. M., Kwon, C., Manley, P. J., Newlander, K. A., Ross, S. T., Samanen, J. M., Uzinskas, I. N., Venslavsky, J. W., Yuan, C. C.-K., Haltiwanger, R. C., Gowen, M., Hwang, S.-M., James, I. E., Lark, M. W., Rieman, D. J., Stroup, G. B., Azzarano, L. M., Salyers, K. L., Smith, B. R., Ward, K. W., Johanson, K. O., Huffman, W. F.
Publikováno v:
Journal of Medicinal Chemistry; January 13, 2000, Vol. 43 Issue: 1 p22-26, 5p
Autor:
Ward KW; Preclinical Drug Discovery, Cardiovascular & Urogenital Center of Excellence in Drug Discovery, GlaxoSmithKline, King of Prussia, PA 19406, USA. keith_w_ward@gsk.com, Azzarano LM, Evans CA, Smith BR
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2004 Apr; Vol. 34 (4), pp. 353-66.
Autor:
Ward KW; Preclinical Drug Discovery, Cardiovascular, Urogenitary, and Oncology Centre for Excellence in Drug Discovery, GlaxoSmithKline R&D, King of Prussia, PA 19406, USA. keith_w_ward@gsk.com, Proksch JW, Salyers KL, Azzarano LM, Morgan JA, Roethke TJ, McSurdy-Freed JE, Levy MA, Smith BR
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2002 Mar; Vol. 32 (3), pp. 221-33.
Autor:
Ward KW; Preclinical Drug Discovery, Cardiovascular, Urogenitary and Oncology Center for Excellence in Drug Discovery, GlaxoSmithKline, King of Prussia, PA 19406, USA. keith_w_ward@gsk.com, Proksch JW, Azzarano LM, Salyers KL, McSurdy-Freed JE, Molnar TM, Levy MA, Smith BR
Publikováno v:
Pharmaceutical research [Pharm Res] 2001 Sep; Vol. 18 (9), pp. 1336-44.
Autor:
Ward KW; Department of Drug Metabolism and Pharmacokinetics, SmithKline Beecham Pharmaceuticals R&D, King of Prussia, Pennsylvania 19406, USA. Keith_W_Ward@sbphrd.com, Azzarano LM, Bondinell WE, Cousins RD, Huffman WF, Jakas DR, Keenan RM, Ku TW, Lundberg D, Miller WH, Mumaw JA, Newlander KA, Pirhalla JL, Roethke TJ, Salyers KL, Souder PR, Stelman GJ, Smith BR
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 1999 Nov; Vol. 27 (11), pp. 1232-41.
Autor:
Miller WH; Research & Development Division, SmithKline Beecham Pharmaceuticals, Collegeville, PA 19426-0989, USA., Bondinell WE, Cousins RD, Erhard KF, Jakas DR, Keenan RM, Ku TW, Newlander KA, Ross ST, Haltiwanger RC, Bradbeer J, Drake FH, Gowen M, Hoffman SJ, Hwang SM, James IE, Lark MW, Lechowska B, Rieman DJ, Stroup GB, Vasko-Moser JA, Zembryki DL, Azzarano LM, Adams PC, Huffman WF, et. al.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 1999 Jul 05; Vol. 9 (13), pp. 1807-12.